echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Important Tips for the CDC! COVID-19 mild, not what you think.

    Important Tips for the CDC! COVID-19 mild, not what you think.

    • Last Update: 2020-08-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Read: The latest study from the CDC COVID-19 Morbidity and Mortality Weekly suggests that patients with MILD COVID-19 infection may have a long time to recover! Currently, there are more than 16.6 million confirmed cases of COVID-19 worldwide, more than 650,000 deaths, and a significant increase in new and confirmed cases.
    has more than 4.34 million cases and nearly 150,000 deaths in the United States.
    's new outbreak of pneumonia, which has shown signs of easing, has worsened sharply again since the weekend.
    cases have risen sharply or outbreaks have returned in several countries around the world, the United Nations and the World Health Organization are deeply concerned about the increase in the outbreak, and many governments have announced the resumption of full or partial closure of quarantine measures.
    traditional thinking, generally mild patients do not need to worry too much, throughout the COVID-19 pandemic, most people think that those who "minor diseases" and those who do not need to stay in the ICU or use a ventilator can survive serious health consequences, and even some countries think that half of the confirmed cases of COVID-19 are mild patients is a "good thing."
    35 percent of patients with mild illness, still suffering from viral symptoms after 2-3 weeks, recently released by the U.S. Centers for Disease Control and Prevention COVID-19 Morbidity and Mortality Weekly, the latest study shows that even in patients with milder conditions, COVID-19 is not so easy to get rid of.
    Photo Source: In a telephone survey involving several U.S. states, Dr. Mark W. Tenforde of the CDC's COVID-19 Emergency Response Group and colleagues responded to a random call call 2-3 weeks after the first CoV-2RT-PCR test positive for adult outpatient patients.
    the survey results: 65 percent of the 274 patients with primary and secondary conditions have returned to health, with the median number of respondents from the date of testing to the return to health being 7 days (IQR - 5-12 days);
    the most common symptoms reported in these patients with minor outpatients were fatigue (71%), cough (61%) and headache (61%).
    call back, the fever and cold symptoms of most patients have eased, while the most difficult symptoms are cough (43% unenopathic) and fatigue (35% unease).
    26 (29%) of the 90 patients who reported shortness of breath at the time of the test still had symptoms.
    reported at test time, and the longest loss of sense of smell and loss of taste (median s 8 days) of the symptoms that had been alleviated prior to the interview.
    , 35% of people with mild illness are still suffering from symptoms such as fatigue, cough, shortness of breath, and so on after 2-3 weeks.
    reason, the CDC COVID-19 emergency response team conducted a statistical analysis and found that there were age differences among people who did not return to normal health: 26%, 32% and 47% of respondents aged 18-34, 35-49, and older than 50, respectively.
    , chronic diseases also affect health recovery: there is no or only one chronic disease, there are two chronic diseases and three or more chronic diseases, the probability of not returning to their normal health status is 28%, 46% and 57%, respectively.
    finally, 19 per cent of those aged 18-34 who did not have chronic diseases had not yet returned to normal health for unknown reasons.
    discussion, more than 90 percent of influenza outpatients recover within about 2 weeks after testing positive, and for most people, THE definition of COVID-19 "light illness" is that there is no need for hospitalization at all, but a small flu can be treated at home for two weeks, but the report clearly shows that even "light" outpatients are more complex, dangerous, and more difficult to get rid of than they were at first thought.
    and according to the author's point of view, the current concept of "light illness" has wrongly guided the public.
    first, patients with "light illness" themselves cannot seriously take correlation information into account when determining the level of risk;
    China's epidemic although has passed the wuhan mode of the big outbreak period, but the local outbreak is still repeated, from Beijing, Urumqi to Dalian, the emergence of the new crown epidemic disrupted many people's lives.
    this report is important to understand the characteristics of COVID-19, we should strongly encourage the public to take preventive measures, including maintaining social distance, frequent hand washing, and proper use of masks in public places to reduce the spread of SARS-CoV-2."
    source and Mortality Weekly Report (MMWR) COVID-19 Can Result in DilongEd Dmorbidit Even in Milder Cases.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.